Company Directory - Research & Development
Invizius is a Scotland based start-up founded by Dr Andy Herbert and Richard Boyd, which aims to reduce the damaging inflammatory effects of dialysis and cardiopulmonary bypass on patients through its patented H-Guard® Priming Solution.
Ixaka is a private UK-based cell and gene therapy company with operations in the UK, Spain and France. We focus on the natural power of the body to cure disease. Our proprietary technologies enhance the inherent therapeutic power of cells by targeting curative cells to the site of disease and by directly modifying cells within the body to improve therapeutic action.
Jubilant Biosys is a subsidiary of Jubilant Life Sciences, servicing as a contract research, development, and manufacturing organization (CRDMO), and has a presence in India and the United States.
Kemio Solutions is a reliable Contract Research and Contract Manufacturing Organization in India, offering single-point access to drug discovery, custom chemical synthesis and pharmaceutical technologies to global pharma and biotech companies.
Kwizda Group has set its sights on finding forward-looking solutions – be it in the development of pharmaceutical drugs, in the sale and distribution thereof or in the dispensing of medicines to patients.
Based in Cambridge, UK, we are a clinical-stage biopharmaceutical company developing a deep pipeline of novel human antibody-based therapies in a broad range of indications
Founded in 1908 and owned by the LEO Foundation, LEO Pharma has devoted decades of research and development to advance the science of dermatology, setting new standards of care for people with skin conditions.
LifeTein, the custom peptide synthesis service company, has developed proprietary PeptideSyn technology. This technology provides a platform for continuous peptide synthesis using microwave technology at a competitive price.
MIMETAS strives to contribute to groundbreaking therapies with unique human disease biology, revealed by robust, screenable assays in the most versatile technology platform.
Macrophage Pharma Ltd is a private UK based biotechnology company founded in 2016 focused on treating human disease by reprogramming macrophage function through transcriptional reprogramming and targeted drug-delivery leveraging its proprietary Esterase Sensitive Motif™ (ESM™) platform.
